Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age (years) | ||||||
 < 60 yr | 1.000 |  |  | 1.000 |  |  |
 ≥ 60 yr | 1.540 | 1.107–2.141 | 0.010 | 1.418 | 1.000–2.011 | 0.050 |
Sex | ||||||
 Male | 1.000 |  |  |  |  |  |
 Female | 1.105 | 0.777–1.571 | 0.577 |  |  |  |
BMI | ||||||
 < 23 | 1.000 |  |  |  |  |  |
 ≥ 23 | 1.020 | 0.735–1.417 | 0.905 |  |  |  |
Surgical approach | ||||||
 Traditional open | 1.000 |  |  |  |  |  |
 Laparoscopic-assisted | 0.918 | 0.640–1.318 | 0.644 |  |  | 0.769 |
Intraoperative blood loss | ||||||
 ≤ 100 ml | 1.000 |  |  | 1.000 |  |  |
 >100 ml | 1.740 | 1.191–2.527 | 0.004 | 1.780 | 1.211–2.617 | 0.003 |
Postoperative complications | ||||||
 Negative | 1.000 |  |  |  |  |  |
 Positive | 1.551 | 1.001–2.404 | 0.050 |  |  | 0.729 |
Tumor length/diameter | ||||||
 < 5 cm | 1.000 |  |  |  |  |  |
 ≥ 5 cm | 1.738 | 1.254–2.408 | 0.001 |  |  | 0.288 |
Histological type | ||||||
 HD/MD/M-LD | 1.000 |  |  |  |  |  |
 LD/MA/SRC | 1.489 | 1.072–2.068 | 0.018 |  |  | 0.094 |
Vascular tumor embolus | ||||||
 Negative | 1.000 |  |  |  |  |  |
 Positive | 1.956 | 1.372–2.789 | < 0.001 |  |  | 0.626 |
Depth of Invasion (T) | ||||||
 T1/T2/T3 | 1.000 |  |  |  |  |  |
 T4a/T4b | 2.133 | 1.525–2.983 | < 0.001 |  |  | 0.526 |
Lymph node metastasis (N) | ||||||
 N0/N1 | 1.000 |  |  |  |  |  |
 N2/N3 | 3.247 | 2.227–4.736 | < 0.001 |  |  | 0.336 |
TNM |  |  | < 0.001 |  |  | < 0.001 |
 IIA | 1.000 |  |  |  |  |  |
 IIB | 2.905 | 1.263–6.680 | 0.012 | 2.667 | 1.158–6.142 | 0.021 |
 IIIA | 4.375 | 2.067–9.259 | < 0.001 | 4.579 | 2.162–9.697 | < 0.001 |
 IIIB | 8.092 | 3.817–17.156 | < 0.001 | 9.092 | 4.277–19.327 | < 0.001 |
 IIIC | 14.987 | 6.776–33.145 | < 0.001 | 16.948 | 7.627–37.662 | < 0.001 |
Serum CEA level | ||||||
 ≤ 5 ng/ml | 1.000 |  |  |  |  |  |
 >5 ng/ml | 1.183 | 0.802–1.744 | 0.396 |  |  |  |
Serum CA199 level | ||||||
 ≤ 37 U/ml | 1.000 |  |  |  |  |  |
 >37 U/ml | 1.333 | 1.082–1.644 | 0.007 |  |  | 0.981 |
Adjuvant chemotherapy cycles |  |  | < 0.001 |  |  | < 0.001 |
 Not received (A) | 1.000 |  |  | 1.000 |  |  |
 7–8 or 10–12 cycles (B) | 0.459 | 0.301–0.699 | < 0.001 | 0.386 | 0.247–0.604 | < 0.001 |
 4–6 or 6–9 cycles (C) | 0.504 | 0.314–0.807 | 0.004 | 0.493 | 0.304–0.800 | 0.004 |
 ≤ 3 or 5 cycles (D) | 1.032 | 0.638–1.670 | 0.897 | 0.870 | 0.530–1.427 | 0.580 |